Zepbound, Eli Lilly’s weight loss medication, became the first FDA-approved drug for obstructive sleep apnea Dec. 20.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA approves Zepbound for obstructive sleep apnea
Zepbound, Eli Lilly’s weight loss medication, became the first FDA-approved drug for obstructive sleep apnea Dec. 20.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis